BETH ISRAEL DEACONESS MEDICAL CENTER

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1896-01-01

Employees: -

Market Cap: -

Website: https://www.bidmc.org/

Clinical Trials

Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic Syndrome

Phase 2

Completed

Conditions: HIV Lipodystrophy

Interventions: Drug: Pioglitazone or metformin
Drug: Leptin
Drug: Placebo

First Posted Date: 2006-08-10

Last Posted Date: 2017-03-23

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 9

Registration Number: NCT00362440

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Endoscopic Implantation of Enteryx for the Treatment of GERD

Not Applicable

Completed

Conditions: Gastroesophageal Reflux

Interventions: Drug: Enteryx

First Posted Date: 2006-06-30

Last Posted Date: 2017-07-21

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 16

Registration Number: NCT00346905

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Effects of Atorvastatin on Myonecrosis

Phase 4

Terminated

Conditions: Coronary Disease

Interventions: Drug: Atorvastatin 80mg
Drug: Placebo Oral Tablet
Other: Screening

First Posted Date: 2006-06-26

Last Posted Date: 2018-01-02

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 97

Registration Number: NCT00344019

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Amino Acids, Serotonin, and Body Weight Regulation

Phase 2

Completed

Conditions: Anorexia Nervosa

Interventions: Other: Branched-chain amino acids

First Posted Date: 2006-06-23

Last Posted Date: 2017-03-23

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 21

Registration Number: NCT00343928

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Glycemic Control to Prevent Cardiac Morbidity in Vascular Surgery

Not Applicable

Terminated

Conditions: Peripheral Vascular Disease
Abdominal Aortic Aneurysm

Interventions: Drug: continuous intravenous insulin infusion

First Posted Date: 2006-05-19

Last Posted Date: 2013-04-17

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 242

Registration Number: NCT00328094

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

TMS for the Treatment of Pancreatic Cancer Pain

Not Applicable

Completed

Conditions: Pancreatic Cancer
Visceral Pain
Pain

Interventions: Procedure: Transcranial Magnetic Stimulation

First Posted Date: 2006-05-11

Last Posted Date: 2017-03-21

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 3

Registration Number: NCT00324428

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Evaluation of DHA for the Treatment of PSC

Phase 1

Completed

Conditions: Primary Sclerosing Cholangitis
Colitis

Interventions: Drug: Docosahexaenoic Acid (DHA)

First Posted Date: 2006-05-11

Last Posted Date: 2015-03-11

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 10

Registration Number: NCT00325013

Locations: 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

Optimizing Fibromyalgia Self-management

Not Applicable

Completed

Conditions: Fibromyalgia

Interventions: Behavioral: Aerobic
Behavioral: Strength training
Behavioral: FSHC
Behavioral: Combination

First Posted Date: 2006-05-04

Last Posted Date: 2017-03-14

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 207

Registration Number: NCT00321659

Laser Light Cues for Gait Freezing in Parkinson's Disease

Not Applicable

Completed

Conditions: Parkinson's Disease

Interventions: Device: 1 mo baseline before visual cue

First Posted Date: 2006-05-03

Last Posted Date: 2017-07-14

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 32

Registration Number: NCT00320242

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
🇺🇸
The Neurological Institute of New York at Columbia University, New York, New York, United States

Study of Amiodarone Given Before Lung Surgery to Prevent Atrial Fibrillation After Lung Resection

Phase 3

Terminated

Conditions: Lung Cancer
Atrial Fibrillation

Interventions: Other: Control arm, standard care
Drug: Amiodarone

First Posted Date: 2006-03-09

Last Posted Date: 2017-04-28

Lead Sponsor: Beth Israel Deaconess Medical Center

Target Recruit Count: 19

Registration Number: NCT00300495

Locations: 🇺🇸
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy